Related Experiment Videos

Carcinogenicity of di(N-nitroso)-perhydropyrimidine (DNPP) after intraperitoneal application to rats

B Bertram, M Habs, M Wiessler

    Cancer Letters
    |January 1, 1979
    PubMed

    Insights

    Di(N-nitroso)-perhydropyrimidine (DNPP) significantly shortened the lifespan of male rats. DNPP exposure also increased the incidence of esophageal and liver tumors in these animals.

    Area of Science:

    • Toxicology
    • Carcinogenesis
    • Animal Studies

    Background:

    • Di(N-nitroso)-perhydropyrimidine (DNPP) is a chemical compound with potential toxicological effects.
    • Understanding the long-term health impacts of DNPP is crucial for risk assessment.

    Purpose of the Study:

    • To investigate the effects of chronic di(N-nitroso)-perhydropyrimidine (DNPP) administration on the lifespan and tumor development in male Sprague-Dawley rats.
    • To determine the dose-dependent carcinogenic potential of DNPP.

    Main Methods:

    • Male Sprague-Dawley rats were administered di(N-nitroso)-perhydropyrimidine (DNPP) intraperitoneally weekly for life.
    • Two dosage groups were used: 30 mg/kg (group I) and 15 mg/kg (group II).
    • Life expectancy and tumor incidence were monitored throughout the study.

    Main Results:

    • DNPP treatment significantly reduced the overall life expectancy in both dosage groups compared to controls.
    • A notable incidence of esophageal tumors was observed: 27% in group I and 33% in group II.
    • A possible increase in liver tumor incidence was also noted: 4% in group I and 8% in group II.

    Conclusions:

    • Chronic exposure to di(N-nitroso)-perhydropyrimidine (DNPP) is associated with reduced lifespan in male rats.
    • DNPP demonstrates carcinogenic potential, particularly for the esophagus, and possibly the liver, in a rodent model.
    • These findings highlight the need for caution regarding DNPP exposure and further investigation into its mechanisms of toxicity.

    Related Concept Videos